Studies have demonstrated that the gain‐of‐function mutation in PIK3CA (the gene encoding p110α, the catalytic subunit) is associated with the overactivation of PI3K, which is an effective mechanism of oncogenesis, especially in breast cancer [5, 24]. This evidence concerns the gene PIK3CB and breast carcinoma.